Back to Search
MATTHEW DAVIS, M.D
M.D
Emergency Medicine Physician
NPI: 1548420193IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
25MA08959400(NJ)
Education
OTHER
Class of 2008
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
PMID 19303695·Eur Urol·2010
4-observational
Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007.
PMID 19665257·J Am Acad Dermatol·2010
8-other
Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer.
PMID 19615720·Urology·2010
8-other
Emerging adults with psychiatric disabilities involved with the criminal justice system.
PMID 19498012·Int J Offender Ther Comp Criminol·2010
8-other
The psychosocial transition associated with spontaneous 46,XX primary ovarian insufficiency: illness uncertainty, stigma, goal flexibility, and purpose in life as factors in emotional health.
PMID 19243752·Fertil Steril·2010
8-other
Patterns of recovery from severe mental illness: a pilot study of outcomes.
PMID 19551505·Community Ment Health J·2010
8-other
Not without my permission: parents' willingness to permit use of newborn screening samples for research.
PMID 19602864·Public Health Genomics·2010
8-other
Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation.
PMID 19074509·FASEB J·2009
7-preclinical
The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels.
PMID 18923087·J Pharmacol Exp Ther·2009
7-preclinical
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
PMID 19008456·Blood·2009
3-trial
Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.
PMID 18989348·Eye (Lond)·2009
3-trial
Weakening of functional corticomuscular coupling during muscle fatigue.
PMID 19028460·Brain Res·2009
8-other
Systematic definition of protein constituents along the major polarization axis reveals an adaptive reuse of the polarization machinery in pheromone-treated budding yeast.
PMID 19053807·J Proteome Res·2009
8-other
Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
PMID 19078950·Neuropsychopharmacology·2009
7-preclinical
Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity.
PMID 18816644·Glia·2009
7-preclinical
Medical management of children with primary hypertension by pediatric subspecialists.
PMID 18781337·Pediatr Nephrol·2009
8-other
Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia.
PMID 18783791·J Pediatr·2009
8-other
Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.
PMID 18698320·Mol Psychiatry·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 355 GRAND ST
JERSEY CITY, NJ 07302 - Phone
- (201) 915-2200
Quick Facts
- NPI
- 1548420193
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile